Chimeric antigen receptor–modified T cells: CD19 and the road beyond
Author:
Affiliation:
1. Immunotherapy Integrated Research Center, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and
2. Department of Medicine, University of Washington, Seattle, WA
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/131/24/2621/1468701/blood785840.pdf
Reference102 articles.
1. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins;Bollard;J Clin Oncol,2014
2. T-cell therapy in the treatment of post-transplant lymphoproliferative disease;Bollard;Nat Rev Clin Oncol,2012
3. Treatment of patients with metastatic cancer using a major histocompatibility complex class II-restricted T-cell receptor targeting the cancer germline antigen MAGE-A3;Lu;J Clin Oncol,2017
4. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response;Robbins;Clin Cancer Res,2015
5. Adoptive cell transfer as personalized immunotherapy for human cancer;Rosenberg;Science,2015
Cited by 123 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123;International Journal of Molecular Sciences;2024-01-25
2. Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review;Frontiers in Oncology;2024-01-23
3. Expanding CAR-T cell immunotherapy horizons through microfluidics;Lab on a Chip;2024
4. Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures;Cancers;2023-12-20
5. Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer;Military Medical Research;2023-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3